0001140361-17-011282.txt : 20170309
0001140361-17-011282.hdr.sgml : 20170309
20170309190825
ACCESSION NUMBER: 0001140361-17-011282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170307
FILED AS OF DATE: 20170309
DATE AS OF CHANGE: 20170309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hartman Thomas E
CENTRAL INDEX KEY: 0001466989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 17679861
MAIL ADDRESS:
STREET 1: HANGER ORTHOPEDIC GROUP, INC.
STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc1.xml
FORM 4
X0306
4
2017-03-07
0
0000722723
HANGER, INC.
HGR
0001466989
Hartman Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP and General Counsel
Common Stock
2017-03-07
4
F
0
281
13.87
D
30238
D
Common Stock
2017-03-08
4
F
0
777
13.77
D
29461
D
Common Stock
2017-03-08
4
A
0
10000
0
A
39461
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 10,000 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017.
Consists of (i) unvested restricted shares which total 10,000 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 9,338 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 4,619 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (v) unvested restricted shares and fully vested shares totaling 3,958 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 1,474 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; (vii) unvested restricted shares and fully vested shares totaling 2,219 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; (viii) fully vested shares totaling 2,008 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012 and (ix) fully vested shares totaling 845 shares from an initial grant of 4,600 shares of restricted stock made on March 25, 2011 and cumulatively vest to the extent of one-quarter each year thereafter, subject to certain provisions under the Company's 2010 Omnibus Incentive Plan and the Plan, and which shall become fully vested upon a termination of employment not involving termination for cause or voluntary termination.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman
2017-03-09